Extracorporeal photopheresis alone or in combination with ruxolitinib for the treatment of chronic graft-versus-host disease
Chronic graft-versus-host disease (cGvHD) is a major cause of morbidity after allogeneic hematopoietic stem cell transplantation. Ruxolitinib (RUX) is a standard second-line treatment for steroid-refractory or -dependent cGvHD, while extracorporeal pho…